NCT01076556 2015-11-11
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Terminated
Clinical Trials
1 trialsTerminated × Leukemia, Lymphocytic, Chronic, B-Cell × cytokine inducible SH2-containing protein × Clear all